Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Amgen Foundation
Awards and Accolades
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Amgen Science Podcasts
Scientific Advisory Boards
Amgen Competitive Grants
Biosimilars
Clinical Trials
Overview
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
Environmental, Social & Governance Report 2022
Environment, Social and Governance Strategy
Healthy People
Overview
Access to Healthcare
Health Equity
Healthy Society
Overview
Diversity, Inclusion and Belonging
Human Capital Management
Community Investment and Amgen Foundation
Supplier Diversity
Healthy Planet
Overview
Environmental Sustainability
Supplier Sustainability
A Healthy Amgen
Overview
Corporate Governance
Business Ethics and Compliance
Ethical Research
Patient Safety
Product Quality
Cybersecurity and Data Privacy
Reporting and Metrics
Overview
Summary of Data
CDP
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
Amgen Worldwide
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
About
Overview
Amgen History
Mission and Values
Leadership
Amgen Foundation
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Human Data
AI & Data Science
Multispecifics & Other Modalities
Clinical Trial Innovation
Pipeline
Amgen Science Podcasts
Scientific Advisory Boards
Amgen Competitive Grants
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
Environmental, Social & Governance Report 2022
Environment, Social and Governance Strategy
Healthy People
Access to Healthcare
Health Equity
Healthy Society
Amgen Foundation and Community Investment
Diversity, Inclusion and Belonging
Human Capital Management
Supplier Diversity
Healthy Planet
Environmental Sustainability
Supplier Sustainability
A Healthy Amgen
Corporate Governance
Business Ethics and Compliance
Ethical Research
Patient Safety
Product Quality
Cybersecurity and Data Privacy
Reporting and Metrics
Summary of Data
CDP
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
X
Home
>
Stories
>
Leadership
>
Leadership Stories
LEADERSHIP
06.01.2023
Bradway at
Financial Times
Summit: Investing in Innovation Is Smart Choice for Aging Societies
Read more
All Stories <i class="fa fa-angle-down"></i><i class="fa fa-angle-up"></i>
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
LEADERSHIP
06.05.2023
Bradway at
Financial Times
Summit: Investing in Innovation Is Smart Choice for Aging Societies
LEADERSHIP
03.30.2023
Amgen CEO Bob Bradway's 2022 Letter to Shareholders
LEADERSHIP
03.23.2023
Three Amgen Leaders Honored for Furthering the Advancement of Women
LEADERSHIP
01.10.2023
At Amgen, It’s "Innovate or Die" Says Amgen CEO Bob Bradway in Interview with Morgan Stanley
LEADERSHIP
11.16.2022
Janet Franklin One of the Fiercest Women in Life Sciences
LEADERSHIP
10.27.2022
Amgen Honored by Foundation of National Institutes of Health
LEADERSHIP
09.16.2022
Amgen Is Ready to Meet Growing Demand for Innovative Medicines, Says Bradway in Bloomberg TV Interview
LEADERSHIP
07.28.2022
CEO’s Advice to Amgen’s Summer Interns? Get "Fired Up" About Biotech
LEADERSHIP
06.02.2022
At Medical Innovation Forum, Bob Bradway Hails Progress Against Cancer and Heart Disease
LEADERSHIP
03.29.2022
Amgen CEO Bob Bradway's 2021 Letter To Shareholders
LEADERSHIP
03.08.2022
Amgen Breaks Ground on New Drug Substance Manufacturing Facility in North Carolina
LEADERSHIP
12.03.2021
Bradway Hails Amgen’s Progress Against 'Undruggable' Disease Targets at Two Healthcare Forums
Load more
Loading...
